Institutional Alpha Dossier
Loading Alpha Data...
MAINBOARD
SYNCING
GMP: ₹-
Est. Listing: Calculating...
01
Bidding Opens
-
Issue Open
02
Bidding Closes
-
Closing Date
03
Basis of Allotment
-
Registrar Finalization
04
Exchange Listing
-
Secondary Debut
Issue Price Valuation
₹-
Upper Cap Price
Price Band Cap:
Book Built / Fixed
Lot Size & Retail Matrix
- Shares
Minimum Market Lot
Min Capital:
₹-
Application Size:
-
Quant Grade & Moat Score
Proprietary Multi-Factor Moat Model
Synthesizing institutional thesis...
💼 MINIMUM INVESTMENT
Capital Matrix
Retail (Min Lot)
Up to ₹2 Lakhs Category
₹ 226800
HNI (Min Lot)
sNII / High Net-Worth Tier
₹ 340200
HNI Capital Multiple:
Institutional Lot Sizing
🍩 RESERVATION QUOTA (%)
Issue Allocation
100%
Total Issue
Anchor
28.41%
Market Maker
5.07%
QIB
18.94%
NII / HNI
14.25%
Retail
33.33%
Institutional Corporate Dossier
Credent Connect
COMPANY PROFILE & DNA
Incorporation / Founded
25-06-15
Active Vintage
Corporate Headquarters
New Delhi, Delhi
Registered Hub
👔 Leadership & Promoter Group
Key Management
Ashok Kumar Sharma, Karan Sharma, Tarun Sharma, Dimple Sharma, Tanveen
⚙️ Business Overview & Portfolio
Core Offerings
Healthcare service provider delivering integrated logistics, workforce solutions, and technology-enabled support.
🎯 Target Market & End-Use
Revenue Drivers
Healthcare logistics and specialized diagnostic sample transportation.
🛡️
★ Unique Selling Proposition (Core Economic Moat)
Comprehensive healthcare ecosystem and logistics platform with well established client relationships and domestic reach.
Objects of the Issue (Use of Proceeds & Allocation)
🎯 Objective 01
Investment in CHPL for working capital
₹ 26.80
Allocation
🎯 Objective 02
Investment in CHPL for machinery
₹ 3.00
Allocation
🎯 Objective 03
Working Capital Requirements
₹ 37.00
Allocation
🎯 Objective 04
Repayment of borrowings
₹ 6.00
Allocation
Financial Performance & Multi-Year Trajectory
All Figures in ₹ Crores
Latest Total Income📊
₹-
Top-Line
EBITDA Margin⚡
-%
Operating
Net Profit (PAT) Margin📈
-%
Bottom-Line
Debt / Net Worth🛡️
-x
Leverage
📊 Income, EBITDA & Profit Growth Trajectory
Income
EBITDA
PAT Trend
🏛️ Balance Sheet: Net Worth vs Debt
Net Worth
Borrowing
| Particulars | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Total Income | 214.43 | 78.23 | 76.02 | |
| EBITDA | 25.97 | 3.95 | 4.12 | |
| Profit After Tax (PAT) | 18.45 | 2.25 | 2.66 | |
| Net Worth | 43.79 | 15.9 | 13.66 | |
| Total Borrowing | 21.95 | 7.42 | 6.85 |
Growth Engine & Compounding Velocity (KPIs)
Multi-Year Trajectory
78.23
₹ Cr
YoY Growth
2.92%
3-Year CAGR
NA
4.99
₹ Cr
YoY Growth
16.26%
3-Year CAGR
NA
2.25
₹ Cr
YoY Growth
-15.68%
3-Year CAGR
NA
Capital Efficiency & Return Ratios (ROE vs ROCE)
Capital Allocation Audit
◈ ROE (Return on Equity)
Calculating...
-%
Current ROE
◈ ROCE (Capital Employed)
Calculating...
-%
Current ROCE
| MetricMetric | Current (%)Curr% | Last Year (%)Last% | 3-Yr Avg (%)3Y Avg | Trend StatusTrend |
|---|---|---|---|---|
| ROE (Return on Equity)ROE | 14.13% | 19.51% | 25.26% | Fluctuating |
| ROCE (Capital Employed)ROCE | 16.96% | 20.00% | 25.65% | Fluctuating |
Forensic Analysis & Reality Check
Earnings Quality & Dilution Audit
1.1
CFO / EBITDA
Cash Flow Conversion Efficiency
Checking...
Analyzing operating cash flow conversion...
| Parameter | Pre-IPO | Post-IPO | View |
|---|---|---|---|
| Debt / Equity | 0.47 | 0.12 | Low |
| EPS (₹) | 1.23 | 10.12 | Accretive |
| ROE (%) | 14.13% | 1.63% | Bad |
| ROCE (%) | 16.96% | 2.48% | Bad |
| P/E (Valuation) | 153.28 | 18.67 | Reasonable |
⏳ Debtor Days Trend (Receivables Cycle)
Analyzing...
FY23
FY24
FY25
Lower receivable days indicate faster cash collection from clients.
⚠️ Contingent Liabilities
Off-Balance Sheet
₹ 0.62 Cr
*Potential hidden obligations & legal/tax claims
Peer Comparison Analysis & Competitive Matrix
Industry Benchmarking
| Company NameComp | Revenue (Cr)Rev | P/E RatioP/E | ROCE (%)ROCE | ROE (%)ROE | OPM (%)OPM |
|---|---|---|---|---|---|
| Credent Connect N Care Limited IPO CANDIDATE | 78.23 | 18.67 (Ask) | 16.96% | 1.63% (Post Issue) | 5.05% |
| NA | 0 | 0 | 0.00% | 0.00% | 0 |
| NA | 0 | 0 | 0.00% | 0.00% | 0 |
| NA | 0 | 0 | 0 | 0 | 0 |
| NA | 0 | 0 | 0 | 0 | 0 |
| NA | 0 | 0 | 0 | 0 | 0 |
▲ Positive Catalysts (Strengths + Opportunities):
8 Factors
▼ Risk Vectors (Weaknesses + Threats):
8 Factors
Strengths
Internal Competitive Moat
- Comprehensive Healthcare Ecosystem and Logistics Platform
- Well established relationships with clients
- Leveraging the experience of our Promoters and Directors
- Widespread reach in domestic markets
Weaknesses
Internal Operational Constraints
- Significant customer concentration with top 10 contributing over 80% revenue
- Dependence on diagnostic and healthcare companies outsourcing testing volumes
- High working capital intensity and significant trade receivables
- Manpower intensive operations relying on skilled geographically dispersed workforce
Opportunities
External Growth Tailwinds
- Expanding service network and geographical reach in domestic markets
- Synergies from integration of newly acquired wholly owned subsidiaries
- Growing outsourcing of logistics by diagnostic laboratories and hospitals
- Leveraging technology to support operational tracking and efficiency
Threats & Risks
External Macro & Sector Headwinds
- Loss of any major customers due to lack of firm commitments
- Supply chain constraints or price increases in specialized packaging materials
- Intense competition from organized and unorganized regional players
- Unsecured loans being recallable at any time by lenders
Top 10 Anchor Investors & Smart-Money Allocation
INSTITUTIONAL BOOK
Top 10 Anchor Commitment
₹- Cr
Smart-Money Quality Score
- / 5.0 ★
Marquee Conviction
SEBI Anchor Lock-In Schedule
30D (50%) • 90D (50%)
Mandatory Lock-In
Anchor Book Allocation Pending Exchange Filing
Institutional anchor investor bidding & allocation disclosures are officially filed with NSE/BSE 1 working day prior to the IPO opening date.
| Rank | Marquee Anchor Institution | Smart-Money Grade | Amount Invested | Anchor Share (%) |
|---|
359.1
Moat Score of 5/10 is based on strong return ratios (ROE and ROCE consistently above 15%) and EBITDA margin expansion (5.67% to 13.29%), offset by high customer concentration (top 10 contributing 81.76%), low entry barriers, and a highly fragmented industry.
28.41
5.07
QIB Quota
Qualified Institutional Buyers
Smart Money
-x
Institutional Book
Inst. Conviction:
Evaluating
NII / HNI Quota
sNII (₹2L-10L) & bNII (₹10L+)
HNI Desk
-x
Non-Institutional
HNI Competition Ratio:
-
Retail (RII) Quota
Individual Investors (Up to ₹2L)
SEBI Lottery
-x
Retail Book
Retail Allotment Odds:
-